-
1
-
-
0022415630
-
Hemostasis defects associated with cardiac surgery, prosthetic devices, and other extracorporeal circuits
-
nromb Hemost 1985;11:249-80.
-
(1985)
nromb Hemost
, vol.11
, pp. 249-280
-
-
Bick, R.L.1
-
2
-
-
0025227931
-
Bleeding complications associated with cardiopulmonary bypass
-
Woodman RC, Harker LA. Bleeding complications associated with cardiopulmonary bypass. Blood 1990;76:1680-97.
-
(1990)
Blood
, vol.76
, pp. 1680-1697
-
-
Woodman, R.C.1
Harker, L.A.2
-
3
-
-
0033967757
-
Systematic off-pump coronary artery revascularization in multivessel disease: Experience of three hundred cases
-
Cartier R, Brann S, Dagenais F, Martineau R, Couturier A. Systematic off-pump coronary artery revascularization in multivessel disease: experience of three hundred cases. J Thorac Cardiovasc Surg 2000;119:221-9.
-
(2000)
J Thorac Cardiovasc Surg
, vol.119
, pp. 221-229
-
-
Cartier, R.1
Brann, S.2
Dagenais, F.3
Martineau, R.4
Couturier, A.5
-
4
-
-
0035323926
-
Reduced postoperative blood loss and transfusion requirement after beating-heart coronary operations: A prospective randomized study
-
Ascione R, Williams S, Lloyd CT, Sundaramoorthi T, Pitsis AA, Angelini GD. Reduced postoperative blood loss and transfusion requirement after beating-heart coronary operations: a prospective randomized study. J Thorac Cardiovasc Surg 2001;121:689-96.
-
(2001)
J Thorac Cardiovasc Surg
, vol.121
, pp. 689-696
-
-
Ascione, R.1
Williams, S.2
Lloyd, C.T.3
Sundaramoorthi, T.4
Pitsis, A.A.5
Angelini, G.D.6
-
5
-
-
0033524140
-
Pharmacological strategies to decrease excessive blood loss in cardiac surgery: A meta-analysis of clinically relevant endpoints
-
Levi M, Cromheecke ME, de Jonge E, Prins MH, de Mol BJ, Briet E, et al. Pharmacological strategies to decrease excessive blood loss in cardiac surgery: a meta-analysis of clinically relevant endpoints. Lancet 1999;354:1940-7.
-
(1999)
Lancet
, vol.354
, pp. 1940-1947
-
-
Levi, M.1
Cromheecke, M.E.2
de Jonge, E.3
Prins, M.H.4
de Mol, B.J.5
Briet, E.6
-
6
-
-
0025757282
-
Prospects for understanding and eliminating the deleterious effects of cardiopulmonary bypass
-
Kirklin JK. Prospects for understanding and eliminating the deleterious effects of cardiopulmonary bypass. Ann Thorac Surg 1991;51:529-31.
-
(1991)
Ann Thorac Surg
, vol.51
, pp. 529-531
-
-
Kirklin, J.K.1
-
7
-
-
0036159195
-
Absence of beneficial effect of acute normovolemic hemodilution combined with aprotinin on allogeneic blood transfusion requirements in cardiac surgery
-
Hohn L, Schweizer A, Licker M, Morel DR. Absence of beneficial effect of acute normovolemic hemodilution combined with aprotinin on allogeneic blood transfusion requirements in cardiac surgery. Anesthesiology 2002;96:276-82.
-
(2002)
Anesthesiology
, vol.96
, pp. 276-282
-
-
Hohn, L.1
Schweizer, A.2
Licker, M.3
Morel, D.R.4
-
8
-
-
0033377015
-
Economic outcome of off-pump coronary artery bypass surgery: A prospective randomized study
-
Ascione R, Lloyd CT, Underwood MJ, Lotto AA, Pitsis AA, Angelini GD. Economic outcome of off-pump coronary artery bypass surgery: a prospective randomized study. Ann Thorac Surg 1999;68:2237-42.
-
(1999)
Ann Thorac Surg
, vol.68
, pp. 2237-2242
-
-
Ascione, R.1
Lloyd, C.T.2
Underwood, M.J.3
Lotto, A.A.4
Pitsis, A.A.5
Angelini, G.D.6
-
9
-
-
0033396840
-
Hemostatic effects of aprotinin, tranexamic acid and epsilon-aminocaproic acid in primary cardiac surgery
-
Casati V, Guzzon D, Oppizzi M, Cossolini M, Torri G, Calori G, et al. Hemostatic effects of aprotinin, tranexamic acid and epsilon-aminocaproic acid in primary cardiac surgery. Ann Thorac Surg 1999;68:2252-7.
-
(1999)
Ann Thorac Surg
, vol.68
, pp. 2252-2257
-
-
Casati, V.1
Guzzon, D.2
Oppizzi, M.3
Cossolini, M.4
Torri, G.5
Calori, G.6
-
10
-
-
0033863978
-
Tranexamic acid compared with high-dose aprotinin in primary elective heart operations: Effects on perioperative bleeding and allogeneic transfusions
-
Casati V, Guzzon D, Oppizzi M, Bellotti F, Franco A, Gerli C, et al. Tranexamic acid compared with high-dose aprotinin in primary elective heart operations: effects on perioperative bleeding and allogeneic transfusions. J Thorac Cardiovasc Surg 2000;120:520-7.
-
(2000)
J Thorac Cardiovasc Surg
, vol.120
, pp. 520-527
-
-
Casati, V.1
Guzzon, D.2
Oppizzi, M.3
Bellotti, F.4
Franco, A.5
Gerli, C.6
-
11
-
-
0032928727
-
Antifibrinolytic therapy with tranexamic acid in cardiac operations
-
Matsuzaki K, Matsui K, Tanoue Y, Nagano I, Haraguchi N, Tatewaki H. Antifibrinolytic therapy with tranexamic acid in cardiac operations. Cardiovasc Surg 1999;7:195-9.
-
(1999)
Cardiovasc Surg
, vol.7
, pp. 195-199
-
-
Matsuzaki, K.1
Matsui, K.2
Tanoue, Y.3
Nagano, I.4
Haraguchi, N.5
Tatewaki, H.6
-
12
-
-
0035644192
-
Systematic elucidation of effects of tranexamic acid on fibrinolysis and bleeding during and after cardiopulmonary bypass surgery
-
Kojima T, Gando S, Morimoto Y, Mashio H, Goda Y, Kawahigashi H, et al. Systematic elucidation of effects of tranexamic acid on fibrinolysis and bleeding during and after cardiopulmonary bypass surgery. Thromb Res 2001;104:301-7.
-
(2001)
Thromb Res
, vol.104
, pp. 301-307
-
-
Kojima, T.1
Gando, S.2
Morimoto, Y.3
Mashio, H.4
Goda, Y.5
Kawahigashi, H.6
-
13
-
-
0028034229
-
Role of factor XII in thrombin generation and fibrinolysis during cardiopulmonary bypass
-
Burman IF, Chung HI, Lane DA, Philippou H, Adami A, Lincoln JC. Role of factor XII in thrombin generation and fibrinolysis during cardiopulmonary bypass. Lancet 1994;344:1192-3.
-
(1994)
Lancet
, vol.344
, pp. 1192-1193
-
-
Burman, I.F.1
Chung, H.I.2
Lane, D.A.3
Philippou, H.4
Adami, A.5
Lincoln, J.C.6
-
14
-
-
0034908049
-
Tranexamic acid in off-pump coronary surgery: A preliminary, randomized, double-blind, placebo-controlled study
-
Casati V, Gerli C, Franco A, Torri G, D'Angelo A, Benussi S, et al. Tranexamic acid in off-pump coronary surgery: a preliminary, randomized, double-blind, placebo-controlled study. Ann Thorac Surg 2001;72:470-5.
-
(2001)
Ann Thorac Surg
, vol.72
, pp. 470-475
-
-
Casati, V.1
Gerli, C.2
Franco, A.3
Torri, G.4
D'Angelo, A.5
Benussi, S.6
-
15
-
-
0035353723
-
Thrombotic complications in beating heart operations
-
Cartier R, Robitaille D. Thrombotic complications in beating heart operations. J Thorac Cardiovasc Surg 2001;121:920-2.
-
(2001)
J Thorac Cardiovasc Surg
, vol.121
, pp. 920-922
-
-
Cartier, R.1
Robitaille, D.2
-
16
-
-
0026739962
-
Aprotinin therapy for reoperative myocardial revascularization: A placebo-controlled study
-
Cosgrove DM 3rd, Heric B, Lytle BW, Taylor PC, Novoa R, Golding LA, et al. Aprotinin therapy for reoperative myocardial revascularization: a placebo-controlled study. Ann Thorac Surg 1992;54:1031-8.
-
(1992)
Ann Thorac Surg
, vol.54
, pp. 1031-1038
-
-
Cosgrove 3rd, D.M.1
Heric, B.2
Lytle, B.W.3
Taylor, P.C.4
Novoa, R.5
Golding, L.A.6
-
17
-
-
23044453721
-
Tranexamic acid and early saphenous vein graft patency in conventional coronary artery bypass graft surgery: A prospective randomized controlled clinical trial
-
Karski J, Djaiani G, Carroll J, Iwanochko M, Seneviratne P, Liu P, et al. Tranexamic acid and early saphenous vein graft patency in conventional coronary artery bypass graft surgery: a prospective randomized controlled clinical trial. J Thorac Cardiovasc Surg 2005;130:309-14.
-
(2005)
J Thorac Cardiovasc Surg
, vol.130
, pp. 309-314
-
-
Karski, J.1
Djaiani, G.2
Carroll, J.3
Iwanochko, M.4
Seneviratne, P.5
Liu, P.6
|